Washington Post

<img alt="" height="1" width="1" />
UPDATE 1-Merck up as Zetia trial less damaging than feared
BOSTON, Nov. 16 (Reuters) - Shares of Merck & Co Inc (MRK.N) rose 2.7 percent on Monday after results of a clinical trial of its cholesterol drug Zetia were not as negative as some analysts had expected. Results of the trial, ...
Merck, Abbott Rise After Cholesterol-Drug StudyWall Street Journal
Cheap Vitamin B Beats Pricier Cholesterol Drug in Clearing ArteriesABC News
New Study Raises New Questions About Cholesterol Drug ZetiaU.S. News & World Report
BusinessWeek -Bloomberg -Milwaukee Journal Sentinel
all 535 news articles &raquo;